Maryland Senate Bill 388

---

Spectrum: Partisan Bill (Democrat 11-0)
Status: Introduced on January 18 2024 - 25% progression, died in committee
Action: 2024-01-24 - Hearing 2/07 at 2:00 p.m. (Finance)
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Requiring the Governor in fiscal year 2025 and each fiscal year thereafter to include in the annual budget bill an appropriation of at least $1,000,000 for the Prescription Drug Affordability Fund which provides funding for the Board; and requiring the Board, under certain circumstances, to establish a process for setting upper payment limits for all purchases and payor reimbursements of prescription drug products in the State that the Board determines have led or will lead to affordability challenges.

Prescription Drug Affordability Board - Authority for Upper Payment Limits and Funding (Lowering Prescription Drug Costs for All Marylanders Act of 2024)

Sen. Dawn Gile [D]	Sen. Brian Feldman [D]	Sen. Pamela Beidle [D]	Sen. Arthur Ellis [D]
Sen. Guy Guzzone [D]	Sen. Katie Hester [D]	Sen. Shelly Hettleman [D]	Sen. Michael Jackson [D]
Sen. Katherine Klausmeier [D]	Sen. Benjamin Kramer [D]	Sen. Clarence Lam [D]

Date	Chamber	Action
2024-01-24	Senate	Hearing 2/07 at 2:00 p.m. (Finance)
2024-01-18	Senate	First Reading Finance and Budget and Taxation

HB340 (Crossfiled) 2024-01-26 - Hearing 2/08 at 1:00 p.m.

Chapter	Article	Section	Citation Type	Statute Text
Health - General	21	2C-11	(n/a)	See Bill Text
Health - General	21	2C-13	(n/a)	See Bill Text
Health - General	21	2C-14	(n/a)	See Bill Text
Health - General	21	2C-16	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB0388?ys=2024RS
Text	https://mgaleg.maryland.gov/2024RS/bills/sb/sb0388f.pdf